Kimmtrak 200 micrograms/mL concentrate for solution for infusion
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 3 recall · DMRC-35860567
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| Kimmtrak 200 micrograms/mL concentrate for solution for infusion | PLGB: 36781/0001 | tebentafusp | 05056416800029 |
Batches (expiry): 3D009AA17 (31/03/2026), 3D009AA19 (31/03/2026), 3D009AA36 (31/03/2026)
Background: Immunocore Limited is recalling the batches listed above as a precautionary measure. The recall is due to a decrease in potency identified during stability testing. All other stability test results remain within specification. Only the batches listed in the above table are impacted. This does not affect other batches that are available. Advice for Healthcare Professionals: